Where is the value in strategic outsourcing partnerships?
Big Pharma perspective and lessons learnt
Where is there scope for strategic CRO partnerships for smaller/biotech sponsors?
So… you have a strategic partnership… how do you capture and prove the value across its many facets?
What’s in a name? Can we FINALLY agree on outsourcing nomclemature definitions and stop confusing everyone?
Mummy, Daddy, where do outsourcing managers come from? Revisiting the evolution of clinical development outsourcing through PCMG’s eyes.
(Event timings subject to change):
09:30: Workshop Registration, tea & coffee
10:00: Session 1 – Redefining CRO sourcing models terminology – Facilitated Discussion; Mark Cooper, SVP Business Development and Commercial Options, ICON
11.00: Refreshment Break
11:30: Session 2 – Capturing Value – A Case Study; Robert Jacob, Alliance Manager Pharma Development, Bayer AG & Kish Khan, Global Commerical Lead, ICON
12.30 Lunch
13.30: Session 3 – Capturing Value – Workshop; Driven by PCMG, ICON and Bayer
14:30: PCMG the evolution of clinical outsourcing; Jean Edwards
15.00: Refreshment Break
15.15: PCMG AGM – Members only
15.30: CRO registration
16.00 PCMG BIG BANG SESSION – open to non-members and CRO delegates
The Possible Impossible – Shalom Lloyd, Co-Founder & Chief Strategy Officer, Emerging Markets Quality Trials (eMQT)
Resourcing Update – Vincent Lody, Managing Director, PharmiWeb
17.00 Evening reception and networking
19:00 Close
THE SECOND ANNUAL PCMG BIG BANG SESSION
SPEAKERS TO BE ANNOUNCED SHORTLY
OPEN TO NON-MEMBERS AND CRO DELEGATES
Registration rates:
Workshop only attendance
Members only = Free
Keynote Session and Drinks Reception attendance
Members = Free
CROs/Suppliers = £95 +VAT
Pharma/Biotech Non members = £95 +VAT
Full attendance
Members = Free
Pharma/Biotech Non members = £150 +VAT